The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints

Hepatocellular carcinoma (HCC) is a challenging malignancy characterised by clinical and biological heterogeneity, independent of the stage. Despite the application of surveillance programs, a substantial proportion of patients are diagnosed at advanced stages when curative treatments are no longer...

Повний опис

Бібліографічні деталі

Автори:	Paolo Giuffrida, Ciro Celsa, Michela Antonucci, Marta Peri, Maria Vittoria Grassini, Gabriele Rancatore, Carmelo Marco Giacchetto, Roberto Cannella, Lorena Incorvaia, Lidia Rita Corsini, Piera Morana, Claudia La Mantia, Giuseppe Badalamenti, Giuseppe Brancatelli, Calogero Cammà, Giuseppe Cabibbo
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2022-11-01
Серія:	Biomedicines
Предмети:	hepatocellular carcinoma HCC systemic therapy immunotherapy endpoints radiological criteria
Онлайн доступ:	https://www.mdpi.com/2227-9059/10/11/2827
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!